Since the election of Prime Minister Justin Trudeau in 2016, Toronto entrepreneurs of all sorts have been opening up marijuana dispensaries and alternative wellness centers in anticipation of Trudeau's promise to legalize marijuana. At the same time, police raids, tainted products, and armed robberies are impacting not only business owners but also the health, safety, and well being of the patrons of these establishments.
Last month, Health Canada licensed producer OrganiGram recalled some of its product because traces of banned pesticides were found in its supply. Now the company is expanding their recall to anything produced since February 2016 - making patients worried, frustrated and out of medicine. Health Canada has been criticized for not releasing information about the pesticides immediately but important details have since been posted online.
The year is 2017. Our phones are a full-on extension of our limbs, and, well, Donald Trump is the President. This equation means my daily free-floating, low-level anxiety isn’t so much cause for alarm as much as it is stating the obvious. To me, anxiety has become a bit of a “chicken or egg” thing: Was I always this anxious, and am I just now letting others in on it; or, in declaring it, does anxiety become more of a self-fulfilling prophecy?
Cannabidiol (CBD) is just one of over 85 scientifically-identified cannabinoids (or chemical compounds) derived from the flowering plant cannabis. Each of the cannabinoids within cannabis elicit unique neurophysiological effects. Most people are well-aware of THC (tetrahydrocannabinol), the predominant cannabinoid within cannabis that is ingested by upwards of 230 million people per year as a psychoactive euphoriant.
As the news of the positive outcomes for some children with uncontrollable epilepsy who have been given a marijuana strain rich in cannabidiol (CBD)—the major non-psychoactive ingredient in marijuana—has spread, desperate parents of children with epilepsy have been clamoring for more information and a chance for their children to try the treatment.
Endocannabinoids are naturally occurring compounds found within the human body. They've been there for 600,000 years or more, but we've only just noticed it.
CBD, or cannabidiol, is quickly changing the debate surrounding the use of marijuana as a medicine.
The University of Saskatchewan is launching a study to test the effectiveness of using cannabis to treat children with epilepsy. The Pediatrics Department will be spearheading the study, which wants to see if a high concentration of cannabidiol (CBD) can be used safely in children with epilepsy and if it will impact seizures and quality of life.
During the 20th century, as modern pharmaceutical products began to replace herbal formularies, cannabis medicines came up against severe opposition in the form of an international prohibition. Doctors were jailed for prescribing it as 1940’s propaganda rippled out across the radiowaves. Cannabis was pushed into the shadows as modern technologies emerged to help form the world we know today. Despite this oppressive reproach, inquisitive scientists were eventually able to both identify the plants’ unique molecules and how they interact within our bodies.